Cervical Cancer Trial, Recruiting NCT07550010 Sponsor: University Hospital, Geneva Condition: Cervical Cancer
Back to Cervical Cancer

Cervical Cancer Trial, Recruiting

NCT07550010
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are HIV-negative and between 30 and 49 years old, or women who are HIV-positive and between 25 and 49 years old
  • People who are able to understand what the study involves and are willing to take part by signing a consent form

Who may not be able to join:

  • People who are pregnant at the time of screening
  • People who have previously had their uterus (womb) surgically removed (hysterectomy)
  • People who have already been diagnosed with cervical cancer
  • People who have symptoms that may suggest cervical cancer, such as unexpected bleeding between periods or a known growth in the pelvic area
  • People who have a condition that makes it difficult for a doctor to examine the cervix properly
  • People who have a serious existing health condition, such as advanced cancer or severe kidney failure
  • People who would not be able to follow the study procedures as required

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 22 37 24 432

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Geneva
Registry
ClinicalTrials.gov
Start date
8 September 2025
Est. completion
8 September 2026

Where this trial is recruiting

Cameroon

Primary endpoints

Diagnostic accuracy of HPV-based screening with digital cytology triage for detection of CIN2+

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov